Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INCYTE CORPINCY · Entity 3182 | EVP & Chief Scientific Officer | August 05, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INCYTE CORP
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 63,648 |
Reported balance
After 2026-08-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-05 · Exercise / conversion · Acquired 2,207 · Balance 63,648 |
| Common StockSEC Table I · non-derivative | Direct | 61,441 |
Reported balance
After 2026-08-05 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-08-05 · Sale · Disposed 2,207 · Balance 61,441 F1: This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $106.47 · Expires 2030-07-01 | Direct | 0 |
Reported balance
After 2026-08-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-05 · Exercise / conversion · Disposed 2,207 · Balance 0 F2: As of August 5th, 2026, the award is fully vested and exercisable |
Filing footnotes · ownership attribution and instrument terms
F1: This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested.
F2: As of August 5th, 2026, the award is fully vested and exercisable
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2026 Filed Aug 7, 2026 20:01 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,207 | $0.00 Strike: $106.47 | $0.00 |
DisclosureSEC source: 0002079962-26-000015 · wk-form4_1786132914.xml · derivative · entry 3 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,207 shares Expires 2030-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: As of August 5th, 2026, the award is fully vested and exercisable Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 20:01 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 2,207 | $123.99 | $273,645.93 |
DisclosureSEC source: 0002079962-26-000015 · wk-form4_1786132914.xml · nonDerivative · entry 2 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,441 F1 · balance_after: This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 20:01 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 2,207 | $106.47 | $234,979.29 |
DisclosureSEC source: 0002079962-26-000015 · wk-form4_1786132914.xml · nonDerivative · entry 1 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,055 | $0.00 Strike: $105.43 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 44 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,055 shares Expires 2027-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As of July 31st, 2026, the award is fully vested and exercisable. Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 6,055 | $120.43 | $729,203.65 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 28 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,441 F1 · balance_after: This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested. Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 6,055 | $105.43 | $638,378.65 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 27 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,496 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 326 | $0.00 Strike: $105.43 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 43 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,055 Underlying: Common Stock · 326 shares Expires 2027-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As of July 31st, 2026, the award is fully vested and exercisable. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 85 | $0.00 Strike: $106.47 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 42 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,207 Underlying: Common Stock · 85 shares Expires 2030-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As of July 31st, 2026, the award is fully vested and exercisable. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,293 | $0.00 Strike: $90.56 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 41 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,293 shares Expires 2031-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As of July 31st, 2026, the award is fully vested and exercisable. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,642 | $0.00 Strike: $85.01 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 40 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,642 shares Expires 2029-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As of July 31st, 2026, the award is fully vested and exercisable. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,623 | $0.00 Strike: $83.58 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 39 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,623 shares Expires 2031-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As of July 31st, 2026, the award is fully vested and exercisable. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,023 | $0.00 Strike: $83.20 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 38 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 202 Underlying: Common Stock · 3,023 shares Expires 2033-01-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As of July 31st, 2026, the award is fully vested and exercisable. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,643 | $0.00 Strike: $80.50 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 37 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,643 shares Expires 2030-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As of July 31st, 2026, the award is fully vested and exercisable. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,864 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 36 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 191 Underlying: Common Stock · 2,864 shares Expires 2032-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As of July 31st, 2026, the award is fully vested and exercisable. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,623 | $0.00 Strike: $74.78 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 35 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,623 shares Expires 2032-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As of July 31st, 2026, the award is fully vested and exercisable. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,459 | $0.00 Strike: $72.27 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 34 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,459 shares Expires 2029-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As of July 31st, 2026, the award is fully vested and exercisable. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,072 | $0.00 Strike: $71.93 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 33 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,665 Underlying: Common Stock · 2,072 shares Expires 2035-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Options granted on January 17, 2025 and will vest monthly through July 15, 2028 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,148 | $0.00 Strike: $68.62 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 32 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,148 shares Expires 2028-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As of July 31st, 2026, the award is fully vested and exercisable. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,709 | $0.00 Strike: $61.76 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 31 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,233 Underlying: Common Stock · 2,709 shares Expires 2033-07-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Options granted on July 14, 2023 and will vest monthly through July 14, 2027 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,284 | $0.00 Strike: $64.25 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 30 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,938 Underlying: Common Stock · 2,284 shares Expires 2034-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options granted on July 15, 2024 and will vest monthly through July 15, 2028 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,918 | $0.00 Strike: $61.18 | $0.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · derivative · entry 29 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,328 Underlying: Common Stock · 2,918 shares Expires 2034-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options granted on January 18, 2024 and will vest monthly through July 14, 2027 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 2,293 | $119.41 | $273,807.13 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 26 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,441 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 326 | $121.69 | $39,670.94 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 25 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,734 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 85 | $122.19 | $10,386.15 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 24 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,060 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 1,642 | $119.38 | $196,021.96 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 23 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,145 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 1,643 | $119.51 | $196,354.93 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 22 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,787 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 2,864 | $119.40 | $341,961.60 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 21 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,430 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 4,695 | $119.39 | $560,536.05 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 20 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,294 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 6,171 | $119.43 | $737,002.53 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 19 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,989 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 2,187 | $119.47 | $261,280.89 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 18 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,160 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 5,332 | $119.42 | $636,747.44 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 17 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,347 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 14,661 | $119.46 | $1,751,403.06 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 16 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,679 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 326 | $105.43 | $34,370.18 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 15 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 85 | $106.47 | $9,049.95 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 14 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 2,293 | $90.56 | $207,654.08 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 13 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 1,642 | $85.01 | $139,586.42 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 12 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 2,623 | $83.58 | $219,230.34 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 11 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 3,023 | $83.20 | $251,513.60 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 10 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 1,643 | $80.50 | $132,261.50 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 9 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 2,864 | $77.67 | $222,446.88 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 8 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 2,623 | $74.78 | $196,147.94 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 7 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 9,459 | $72.27 | $683,601.93 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 6 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 2,072 | $71.93 | $149,038.96 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 5 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 3,148 | $68.62 | $216,015.76 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 4 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 2,709 | $61.76 | $167,307.84 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 3 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 2,284 | $64.25 | $146,747.00 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 2 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 2,918 | $61.18 | $178,523.24 |
DisclosureSEC source: 0002079962-26-000013 · wk-form4_1785873838.xml · nonDerivative · entry 1 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 16, 2026 Filed Jul 20, 2026 20:10 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 25,538 | $0.00 Strike: $116.65 | $0.00 |
DisclosureSEC source: 0002079962-26-000011 · wk-form4_1784578199.xml · derivative · entry 3 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,538 Underlying: Common Stock · 25,538 shares Expires 2036-07-15 F4 · derivative.exercise_date: The July 16, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Remarks: Read SEC document |
| July 16, 2026 Filed Jul 20, 2026 20:10 UTC | INCYTE CORP INCY · Entity 3182 | GrantPerformance Shares · Derivative | 14,790 | $0.00 | $0.00 |
DisclosureSEC source: 0002079962-26-000011 · wk-form4_1784578199.xml · derivative · entry 2 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,790 Underlying: Common Stock · 14,790 shares Expires 2029-07-16 F3 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. F3 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. Read SEC document |
| July 16, 2026 Filed Jul 20, 2026 20:10 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 5,916 | $0.00 | $0.00 |
DisclosureSEC source: 0002079962-26-000011 · wk-form4_1784578199.xml · nonDerivative · entry 1 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,628 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Including the July 16, 2026 grant, this includes an aggregate of 74,327 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.